Simpler Grants.gov #PAR-24-216

FDA Grant for Development of Minor Use/Minor Species Animal Drugs (MUMS)

This opportunity is a grant solicitation from the Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) to support the development of new animal drugs for minor uses in major species or for use in minor species (MUMS). - Government Buyer: - Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM) - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a research grant for drug development - Products/Services Requested: - Research and development services for new animal drugs intended for minor uses in major species or for use in minor species - Includes qualified safety and effectiveness testing required for FDA approval of MUMS-designated drugs - No specific products, part numbers, or purchase quantities are listed - Unique or Notable Requirements: - Applicants must have an open Investigational New Animal Drug (INAD) file - Applicants must have a minor use or minor species designation from FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) - Study protocol must be reviewed and concurred by the Office of New Animal Drug Evaluation (ONADE) prior to submission - Eligible applicants include entities developing veterinary drugs or their research partners - Period of performance is tied to the grant's closing date, with a maximum award amount of $250,000 per grant - Place of performance and contracting office is the FDA

Description

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), soliciting Research Project (R01) grant applications to develop or support the development of designated new animal drugs for minor uses in major species or for use in minor species (MUMS). The FDA provides grants to assist in defraying costs of qualified safety and effectiveness testing for FDA approval of MUMS-designated drugs. Eligible applicants include entities developing veterinary drugs or research partners, with specific requirements such as having an Investigational New Animal Drug (INAD) file and a minor use or minor species designation granted by FDA/CVM.

View original listing